FMP
May 14, 2025 6:00 PM - Danny Green
Image credit: Google Images
KP Tissue Inc. (TSX:KPT), a prominent player in the Canadian tissue product market, known for its popular brands like Cashmere® and Purex®, operates alongside Kruger Products Inc., serving both consumer and Away-From-Home markets. Recently, KPTSF, its U.S. counterpart trading on the PNK exchange, reported its Q1 2025 earnings, revealing mixed financial results.
On May 14, 2025, KPTSF announced an earnings per share (EPS) of $0.09, exceeding the forecasted EPS of $0.06. This indicates a stronger-than-expected profitability for the quarter. However, the company's revenue of approximately $379.5 million fell short of the anticipated $515.5 million, highlighting a gap in expected sales performance.
During the Q1 2025 earnings call, CEO Dino Bianco and CFO Michael Keays addressed these results. The call, attended by major financial institutions like CIBC Capital Markets and TD Cowen, provided insights into the company's financial health. Despite the revenue shortfall, the positive EPS suggests effective cost management or other operational efficiencies.
KPTSF's financial metrics offer further context. With a price-to-earnings (P/E) ratio of 34.75, investors are paying 34.75 times the company's earnings, indicating high market expectations. The enterprise value to operating cash flow ratio of 24.24 suggests the company is valued at 24.24 times its operating cash flow, reflecting investor confidence in its cash-generating ability.
The company's current ratio of 1 shows a balanced short-term financial position, with current assets equaling current liabilities. This stability, combined with an earnings yield of 2.88%, provides a comprehensive view of KPTSF's financial standing, despite the revenue miss.
Sep 10, 2024 7:33 AM - Parth Sanghvi
When it comes to downloading historical stock data, Yahoo Finance has been a popular choice for many. However, for those looking for more comprehensive, accurate, and flexible options, Financial Modeling Prep (FMP) offers a suite of powerful tools and services that stand out as superior alternatives...
Nov 8, 2024 5:30 AM - Sanzhi Kobzhan
When it comes to investing in stocks, one of the key decisions an investor must make involves determining the intrinsic value of a company's shares. Equity valuation isn't just about numbers, it's an art mixed with science, aiming to predict future performance based on current and historical data. H...
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...